跳至主要内容
临床试验/CTRI/2021/09/036600
CTRI/2021/09/036600尚未招募2 期

Efficacy of Natroon Banjawi and Sirka as Zimad in Tinea corporis-A pilot study - Tinea corporis

Rajiv Gandhi University of Health Sciences Karnataka Bangalore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient of tinea corporis attending OPD of NIUM hospital (Confirmed by direct microscopy).
  • Patient of either gender.
  • Age group 18-60 years.
  • Patient who have agreed to sign the informed consent form, comply with the study procedure, and availability for regular follow up during the protocol.

排除标准

  • Patient below 18 years and above 60 years of age
  • Patient with sever systemic illness like Diabetic, malignancy etc
  • HIV/AIDS or other immunocompromised patients
  • Patient with other skin diseases like Erythrasma, Candida intertrigo, Intertriginous Psoriasis, Pityriasis versicolor.

研究者

发起方
Rajiv Gandhi University of Health Sciences Karnataka Bangalore

相似试验